HEADER HYDROLASE INHIBITOR 29-JUN-06 2HI9 TITLE CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMA SERINE PROTEASE INHIBITOR; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: RESIDUES 25-387; COMPND 5 SYNONYM: PCI, PROTEIN C INHIBITOR, PLASMINOGEN ACTIVATOR INHIBITOR 3, COMPND 6 PAI-3, PAI3, ACROSOMAL SERINE PROTEASE INHIBITOR; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SERPINA5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SERPIN, COAGULATION, HAEMOSTASIS, THROMBIN INHIBITOR, ACTIVATED KEYWDS 2 PROTEIN C INHIBITOR, ACROSIN INHIBITOR, SERINE PROTEASE INHIBITOR, KEYWDS 3 HYDROLASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR W.LI,T.E.ADAMS,J.A.HUNTINGTON REVDAT 5 13-MAR-24 2HI9 1 REMARK REVDAT 4 13-JUL-11 2HI9 1 VERSN REVDAT 3 24-FEB-09 2HI9 1 VERSN REVDAT 2 27-MAR-07 2HI9 1 JRNL REVDAT 1 13-MAR-07 2HI9 0 JRNL AUTH W.LI,T.E.ADAMS,M.KJELLBERG,J.STENFLO,J.A.HUNTINGTON JRNL TITL STRUCTURE OF NATIVE PROTEIN C INHIBITOR PROVIDES INSIGHT JRNL TITL 2 INTO ITS MULTIPLE FUNCTIONS. JRNL REF J.BIOL.CHEM. V. 282 13759 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17337440 JRNL DOI 10.1074/JBC.M701074200 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2317208.500 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 60214 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2449 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 9434 REMARK 3 BIN R VALUE (WORKING SET) : 0.3390 REMARK 3 BIN FREE R VALUE : 0.3760 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 400 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8270 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 382 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.99000 REMARK 3 B22 (A**2) : 6.08000 REMARK 3 B33 (A**2) : -2.08000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.54000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.33 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.44 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.770 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.570 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.650 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.230 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.340 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 47.58 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 4 : CITRATE2.PARAM REMARK 3 PARAMETER FILE 5 : GLYCEROL.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 4 : CITRATE2.TOP REMARK 3 TOPOLOGY FILE 5 : GLYCEROL.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HI9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-JUL-06. REMARK 100 THE DEPOSITION ID IS D_1000038377. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : SI (111) CRYTALS REMARK 200 OPTICS : MONOCHROMATOR IS ONE OF TWO REMARK 200 ASSYMETRIC CUT SI (111) CRYTALS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60523 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.39600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 66.7MM TRI-POTASSIUM CITRATE, 6.7% REMARK 280 PEG3350, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 99.29500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.47500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 99.29500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.47500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1125 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 353 REMARK 465 ARG A 354 REMARK 465 SER A 355 REMARK 465 ALA A 356 REMARK 465 ARG A 357 REMARK 465 LEU A 358 REMARK 465 ASN A 359 REMARK 465 SER B 25 REMARK 465 ARG B 26 REMARK 465 ASN B 79 REMARK 465 LEU B 80 REMARK 465 GLN B 81 REMARK 465 ARG B 354 REMARK 465 SER B 355 REMARK 465 ALA B 356 REMARK 465 ARG B 357 REMARK 465 THR C 341 REMARK 465 ARG C 342 REMARK 465 ALA C 343 REMARK 465 ALA C 344 REMARK 465 ALA C 345 REMARK 465 ALA C 346 REMARK 465 THR C 347 REMARK 465 GLY C 348 REMARK 465 THR C 349 REMARK 465 ILE C 350 REMARK 465 PHE C 351 REMARK 465 THR C 352 REMARK 465 PHE C 353 REMARK 465 ARG C 354 REMARK 465 SER C 355 REMARK 465 ALA C 356 REMARK 465 ARG C 357 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 82 NZ REMARK 470 ARG A 103 NE CZ NH1 NH2 REMARK 470 LYS A 164 CE NZ REMARK 470 ASN A 175 CG OD1 ND2 REMARK 470 LYS A 273 CG CD CE NZ REMARK 470 ILE A 350 CG1 CG2 CD1 REMARK 470 ARG B 27 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 74 CG CD OE1 OE2 REMARK 470 LYS B 82 CG CD CE NZ REMARK 470 SER B 84 OG REMARK 470 LYS B 86 CG CD CE NZ REMARK 470 GLU B 87 CG CD OE1 OE2 REMARK 470 GLN B 101 CG CD OE1 NE2 REMARK 470 LYS B 164 CD CE NZ REMARK 470 GLN B 241 CG CD OE1 NE2 REMARK 470 LYS B 266 CD CE NZ REMARK 470 LYS B 276 CG CD CE NZ REMARK 470 LYS B 277 CE NZ REMARK 470 ILE B 350 CG1 CG2 CD1 REMARK 470 GLN C 101 CG CD OE1 NE2 REMARK 470 ASP C 104 CG OD1 OD2 REMARK 470 PHE C 106 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS C 189 CE NZ REMARK 470 LYS C 197 CG CD CE NZ REMARK 470 LYS C 266 CG CD CE NZ REMARK 470 ARG C 269 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 273 CG CD CE NZ REMARK 470 MET C 274 CG SD CE REMARK 470 LYS C 276 CG CD CE NZ REMARK 470 LEU C 358 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO C 42 C - N - CA ANGL. DEV. = 11.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 66 -130.04 40.23 REMARK 500 ASP A 104 -99.94 10.41 REMARK 500 PHE A 106 54.32 -156.76 REMARK 500 LYS A 187 114.21 -160.74 REMARK 500 ARG A 219 128.06 -175.16 REMARK 500 LEU A 226 139.76 -175.74 REMARK 500 SER A 232 67.88 72.89 REMARK 500 VAL A 298 -50.98 -126.54 REMARK 500 PHE A 351 125.61 74.30 REMARK 500 ASP A 375 81.08 -155.19 REMARK 500 ASN A 376 -46.58 69.78 REMARK 500 PHE B 29 -65.17 -24.93 REMARK 500 LEU B 62 -6.85 -59.45 REMARK 500 SER B 66 -135.61 31.35 REMARK 500 SER B 83 -44.09 72.03 REMARK 500 ASN B 100 4.56 -68.71 REMARK 500 PRO B 102 100.62 -49.55 REMARK 500 ASP B 104 127.42 5.61 REMARK 500 PHE B 106 70.23 -174.18 REMARK 500 ALA B 113 143.20 -171.96 REMARK 500 ASP B 145 76.21 -106.65 REMARK 500 ASP B 167 45.32 -142.08 REMARK 500 LYS B 187 105.20 -169.07 REMARK 500 ARG B 219 127.98 -170.31 REMARK 500 ARG B 219 127.19 -171.15 REMARK 500 ASP B 221 -179.76 176.35 REMARK 500 LEU B 226 136.91 178.76 REMARK 500 SER B 232 70.27 64.65 REMARK 500 GLU B 253 125.40 -32.02 REMARK 500 ASN B 322 36.70 -79.84 REMARK 500 GLN B 324 147.27 -175.19 REMARK 500 ASP B 375 75.85 -154.31 REMARK 500 ASN B 376 -42.37 76.08 REMARK 500 ARG C 27 134.64 -30.87 REMARK 500 PRO C 42 -64.48 -19.41 REMARK 500 SER C 43 65.27 -113.28 REMARK 500 SER C 66 -136.60 41.44 REMARK 500 ARG C 103 99.36 165.02 REMARK 500 PHE C 106 38.12 88.70 REMARK 500 ASP C 221 -170.50 -178.80 REMARK 500 SER C 232 65.63 69.76 REMARK 500 LYS C 273 -72.55 -82.53 REMARK 500 ASN C 319 43.82 -102.54 REMARK 500 ASN C 322 36.91 -90.08 REMARK 500 ASN C 359 59.05 39.48 REMARK 500 ASP C 375 87.27 176.11 REMARK 500 ASN C 376 -45.02 71.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT C 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 2001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LQ8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR DBREF 2HI9 A 25 387 UNP P05154 IPSP_HUMAN 44 406 DBREF 2HI9 B 25 387 UNP P05154 IPSP_HUMAN 44 406 DBREF 2HI9 C 25 387 UNP P05154 IPSP_HUMAN 44 406 SEQRES 1 A 363 SER ARG ARG ASP PHE THR PHE ASP LEU TYR ARG ALA LEU SEQRES 2 A 363 ALA SER ALA ALA PRO SER GLN ASN ILE PHE PHE SER PRO SEQRES 3 A 363 VAL SER ILE SER MET SER LEU ALA MET LEU SER LEU GLY SEQRES 4 A 363 ALA GLY SER SER THR LYS MET GLN ILE LEU GLU GLY LEU SEQRES 5 A 363 GLY LEU ASN LEU GLN LYS SER SER GLU LYS GLU LEU HIS SEQRES 6 A 363 ARG GLY PHE GLN GLN LEU LEU GLN GLU LEU ASN GLN PRO SEQRES 7 A 363 ARG ASP GLY PHE GLN LEU SER LEU GLY ASN ALA LEU PHE SEQRES 8 A 363 THR ASP LEU VAL VAL ASP LEU GLN ASP THR PHE VAL SER SEQRES 9 A 363 ALA MET LYS THR LEU TYR LEU ALA ASP THR PHE PRO THR SEQRES 10 A 363 ASN PHE ARG ASP SER ALA GLY ALA MET LYS GLN ILE ASN SEQRES 11 A 363 ASP TYR VAL ALA LYS GLN THR LYS GLY LYS ILE VAL ASP SEQRES 12 A 363 LEU LEU LYS ASN LEU ASP SER ASN ALA VAL VAL ILE MET SEQRES 13 A 363 VAL ASN TYR ILE PHE PHE LYS ALA LYS TRP GLU THR SER SEQRES 14 A 363 PHE ASN HIS LYS GLY THR GLN GLU GLN ASP PHE TYR VAL SEQRES 15 A 363 THR SER GLU THR VAL VAL ARG VAL PRO MET MET SER ARG SEQRES 16 A 363 GLU ASP GLN TYR HIS TYR LEU LEU ASP ARG ASN LEU SER SEQRES 17 A 363 CYS ARG VAL VAL GLY VAL PRO TYR GLN GLY ASN ALA THR SEQRES 18 A 363 ALA LEU PHE ILE LEU PRO SER GLU GLY LYS MET GLN GLN SEQRES 19 A 363 VAL GLU ASN GLY LEU SER GLU LYS THR LEU ARG LYS TRP SEQRES 20 A 363 LEU LYS MET PHE LYS LYS ARG GLN LEU GLU LEU TYR LEU SEQRES 21 A 363 PRO LYS PHE SER ILE GLU GLY SER TYR GLN LEU GLU LYS SEQRES 22 A 363 VAL LEU PRO SER LEU GLY ILE SER ASN VAL PHE THR SER SEQRES 23 A 363 HIS ALA ASP LEU SER GLY ILE SER ASN HIS SER ASN ILE SEQRES 24 A 363 GLN VAL SER GLU MET VAL HIS LYS ALA VAL VAL GLU VAL SEQRES 25 A 363 ASP GLU SER GLY THR ARG ALA ALA ALA ALA THR GLY THR SEQRES 26 A 363 ILE PHE THR PHE ARG SER ALA ARG LEU ASN SER GLN ARG SEQRES 27 A 363 LEU VAL PHE ASN ARG PRO PHE LEU MET PHE ILE VAL ASP SEQRES 28 A 363 ASN ASN ILE LEU PHE LEU GLY LYS VAL ASN ARG PRO SEQRES 1 B 363 SER ARG ARG ASP PHE THR PHE ASP LEU TYR ARG ALA LEU SEQRES 2 B 363 ALA SER ALA ALA PRO SER GLN ASN ILE PHE PHE SER PRO SEQRES 3 B 363 VAL SER ILE SER MET SER LEU ALA MET LEU SER LEU GLY SEQRES 4 B 363 ALA GLY SER SER THR LYS MET GLN ILE LEU GLU GLY LEU SEQRES 5 B 363 GLY LEU ASN LEU GLN LYS SER SER GLU LYS GLU LEU HIS SEQRES 6 B 363 ARG GLY PHE GLN GLN LEU LEU GLN GLU LEU ASN GLN PRO SEQRES 7 B 363 ARG ASP GLY PHE GLN LEU SER LEU GLY ASN ALA LEU PHE SEQRES 8 B 363 THR ASP LEU VAL VAL ASP LEU GLN ASP THR PHE VAL SER SEQRES 9 B 363 ALA MET LYS THR LEU TYR LEU ALA ASP THR PHE PRO THR SEQRES 10 B 363 ASN PHE ARG ASP SER ALA GLY ALA MET LYS GLN ILE ASN SEQRES 11 B 363 ASP TYR VAL ALA LYS GLN THR LYS GLY LYS ILE VAL ASP SEQRES 12 B 363 LEU LEU LYS ASN LEU ASP SER ASN ALA VAL VAL ILE MET SEQRES 13 B 363 VAL ASN TYR ILE PHE PHE LYS ALA LYS TRP GLU THR SER SEQRES 14 B 363 PHE ASN HIS LYS GLY THR GLN GLU GLN ASP PHE TYR VAL SEQRES 15 B 363 THR SER GLU THR VAL VAL ARG VAL PRO MET MET SER ARG SEQRES 16 B 363 GLU ASP GLN TYR HIS TYR LEU LEU ASP ARG ASN LEU SER SEQRES 17 B 363 CYS ARG VAL VAL GLY VAL PRO TYR GLN GLY ASN ALA THR SEQRES 18 B 363 ALA LEU PHE ILE LEU PRO SER GLU GLY LYS MET GLN GLN SEQRES 19 B 363 VAL GLU ASN GLY LEU SER GLU LYS THR LEU ARG LYS TRP SEQRES 20 B 363 LEU LYS MET PHE LYS LYS ARG GLN LEU GLU LEU TYR LEU SEQRES 21 B 363 PRO LYS PHE SER ILE GLU GLY SER TYR GLN LEU GLU LYS SEQRES 22 B 363 VAL LEU PRO SER LEU GLY ILE SER ASN VAL PHE THR SER SEQRES 23 B 363 HIS ALA ASP LEU SER GLY ILE SER ASN HIS SER ASN ILE SEQRES 24 B 363 GLN VAL SER GLU MET VAL HIS LYS ALA VAL VAL GLU VAL SEQRES 25 B 363 ASP GLU SER GLY THR ARG ALA ALA ALA ALA THR GLY THR SEQRES 26 B 363 ILE PHE THR PHE ARG SER ALA ARG LEU ASN SER GLN ARG SEQRES 27 B 363 LEU VAL PHE ASN ARG PRO PHE LEU MET PHE ILE VAL ASP SEQRES 28 B 363 ASN ASN ILE LEU PHE LEU GLY LYS VAL ASN ARG PRO SEQRES 1 C 363 SER ARG ARG ASP PHE THR PHE ASP LEU TYR ARG ALA LEU SEQRES 2 C 363 ALA SER ALA ALA PRO SER GLN ASN ILE PHE PHE SER PRO SEQRES 3 C 363 VAL SER ILE SER MET SER LEU ALA MET LEU SER LEU GLY SEQRES 4 C 363 ALA GLY SER SER THR LYS MET GLN ILE LEU GLU GLY LEU SEQRES 5 C 363 GLY LEU ASN LEU GLN LYS SER SER GLU LYS GLU LEU HIS SEQRES 6 C 363 ARG GLY PHE GLN GLN LEU LEU GLN GLU LEU ASN GLN PRO SEQRES 7 C 363 ARG ASP GLY PHE GLN LEU SER LEU GLY ASN ALA LEU PHE SEQRES 8 C 363 THR ASP LEU VAL VAL ASP LEU GLN ASP THR PHE VAL SER SEQRES 9 C 363 ALA MET LYS THR LEU TYR LEU ALA ASP THR PHE PRO THR SEQRES 10 C 363 ASN PHE ARG ASP SER ALA GLY ALA MET LYS GLN ILE ASN SEQRES 11 C 363 ASP TYR VAL ALA LYS GLN THR LYS GLY LYS ILE VAL ASP SEQRES 12 C 363 LEU LEU LYS ASN LEU ASP SER ASN ALA VAL VAL ILE MET SEQRES 13 C 363 VAL ASN TYR ILE PHE PHE LYS ALA LYS TRP GLU THR SER SEQRES 14 C 363 PHE ASN HIS LYS GLY THR GLN GLU GLN ASP PHE TYR VAL SEQRES 15 C 363 THR SER GLU THR VAL VAL ARG VAL PRO MET MET SER ARG SEQRES 16 C 363 GLU ASP GLN TYR HIS TYR LEU LEU ASP ARG ASN LEU SER SEQRES 17 C 363 CYS ARG VAL VAL GLY VAL PRO TYR GLN GLY ASN ALA THR SEQRES 18 C 363 ALA LEU PHE ILE LEU PRO SER GLU GLY LYS MET GLN GLN SEQRES 19 C 363 VAL GLU ASN GLY LEU SER GLU LYS THR LEU ARG LYS TRP SEQRES 20 C 363 LEU LYS MET PHE LYS LYS ARG GLN LEU GLU LEU TYR LEU SEQRES 21 C 363 PRO LYS PHE SER ILE GLU GLY SER TYR GLN LEU GLU LYS SEQRES 22 C 363 VAL LEU PRO SER LEU GLY ILE SER ASN VAL PHE THR SER SEQRES 23 C 363 HIS ALA ASP LEU SER GLY ILE SER ASN HIS SER ASN ILE SEQRES 24 C 363 GLN VAL SER GLU MET VAL HIS LYS ALA VAL VAL GLU VAL SEQRES 25 C 363 ASP GLU SER GLY THR ARG ALA ALA ALA ALA THR GLY THR SEQRES 26 C 363 ILE PHE THR PHE ARG SER ALA ARG LEU ASN SER GLN ARG SEQRES 27 C 363 LEU VAL PHE ASN ARG PRO PHE LEU MET PHE ILE VAL ASP SEQRES 28 C 363 ASN ASN ILE LEU PHE LEU GLY LYS VAL ASN ARG PRO HET CIT A1001 13 HET CIT B1002 13 HET GOL B2001 6 HET CIT C1003 13 HETNAM CIT CITRIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 CIT 3(C6 H8 O7) FORMUL 6 GOL C3 H8 O3 FORMUL 8 HOH *382(H2 O) HELIX 1 1 ASP A 28 ALA A 41 1 14 HELIX 2 2 SER A 49 SER A 61 1 13 HELIX 3 3 LEU A 62 ALA A 64 5 3 HELIX 4 4 GLY A 65 LEU A 76 1 12 HELIX 5 5 SER A 84 ASN A 100 1 17 HELIX 6 6 GLN A 123 TYR A 134 1 12 HELIX 7 7 ASP A 145 THR A 161 1 17 HELIX 8 8 LYS A 255 LEU A 263 1 9 HELIX 9 9 SER A 264 PHE A 275 1 12 HELIX 10 10 GLU A 296 GLY A 303 5 8 HELIX 11 11 SER A 305 THR A 309 5 5 HELIX 12 12 ASP B 28 ALA B 41 1 14 HELIX 13 13 SER B 49 LEU B 62 1 14 HELIX 14 14 GLY B 65 GLY B 77 1 13 HELIX 15 15 SER B 84 ASN B 100 1 17 HELIX 16 16 GLN B 123 LEU B 135 1 13 HELIX 17 17 ASP B 145 THR B 161 1 17 HELIX 18 18 LYS B 255 LEU B 263 1 9 HELIX 19 19 SER B 264 PHE B 275 1 12 HELIX 20 20 GLU B 296 VAL B 298 5 3 HELIX 21 21 LEU B 299 GLY B 303 5 5 HELIX 22 22 SER B 305 THR B 309 5 5 HELIX 23 23 ASP C 28 ALA C 41 1 14 HELIX 24 24 SER C 49 LEU C 62 1 14 HELIX 25 25 GLY C 65 LEU C 76 1 12 HELIX 26 26 SER C 84 ASN C 100 1 17 HELIX 27 27 GLN C 123 LEU C 135 1 13 HELIX 28 28 ASP C 145 THR C 161 1 17 HELIX 29 29 ASN C 195 THR C 199 5 5 HELIX 30 30 LYS C 255 LEU C 263 1 9 HELIX 31 31 SER C 264 PHE C 275 1 12 HELIX 32 32 LEU C 295 LEU C 299 1 5 HELIX 33 33 PRO C 300 GLY C 303 5 4 HELIX 34 34 SER C 305 THR C 309 5 5 SHEET 1 A 7 ILE A 46 PHE A 48 0 SHEET 2 A 7 ILE A 378 VAL A 384 -1 O LYS A 383 N ILE A 46 SHEET 3 A 7 PHE A 369 VAL A 374 -1 N PHE A 369 O VAL A 384 SHEET 4 A 7 THR A 245 PRO A 251 -1 N LEU A 247 O PHE A 372 SHEET 5 A 7 CYS A 233 PRO A 239 -1 N VAL A 238 O ALA A 246 SHEET 6 A 7 VAL A 211 ASP A 228 -1 N ASP A 228 O CYS A 233 SHEET 7 A 7 GLN A 200 TYR A 205 -1 N GLN A 200 O MET A 216 SHEET 1 B 8 ILE A 46 PHE A 48 0 SHEET 2 B 8 ILE A 378 VAL A 384 -1 O LYS A 383 N ILE A 46 SHEET 3 B 8 PHE A 369 VAL A 374 -1 N PHE A 369 O VAL A 384 SHEET 4 B 8 THR A 245 PRO A 251 -1 N LEU A 247 O PHE A 372 SHEET 5 B 8 CYS A 233 PRO A 239 -1 N VAL A 238 O ALA A 246 SHEET 6 B 8 VAL A 211 ASP A 228 -1 N ASP A 228 O CYS A 233 SHEET 7 B 8 LYS A 276 PRO A 285 -1 O LEU A 284 N MET A 217 SHEET 8 B 8 GLN A 361 VAL A 364 1 O LEU A 363 N GLU A 281 SHEET 1 C 5 ASP A 137 THR A 141 0 SHEET 2 C 5 PHE A 106 ASP A 117 1 N LEU A 114 O PHE A 139 SHEET 3 C 5 VAL A 178 ALA A 188 -1 O ILE A 179 N PHE A 115 SHEET 4 C 5 GLU A 327 VAL A 336 1 O VAL A 329 N MET A 180 SHEET 5 C 5 PHE A 287 GLN A 294 -1 N PHE A 287 O VAL A 336 SHEET 1 D 2 TRP A 190 THR A 192 0 SHEET 2 D 2 GLY A 340 ARG A 342 1 O THR A 341 N TRP A 190 SHEET 1 E 7 ILE B 46 PHE B 48 0 SHEET 2 E 7 ILE B 378 VAL B 384 -1 O LYS B 383 N ILE B 46 SHEET 3 E 7 PHE B 369 VAL B 374 -1 N MET B 371 O GLY B 382 SHEET 4 E 7 THR B 245 PRO B 251 -1 N THR B 245 O VAL B 374 SHEET 5 E 7 CYS B 233 PRO B 239 -1 N VAL B 238 O ALA B 246 SHEET 6 E 7 VAL B 211 ASP B 228 -1 N ASP B 228 O CYS B 233 SHEET 7 E 7 GLN B 200 TYR B 205 -1 N PHE B 204 O VAL B 212 SHEET 1 F 8 ILE B 46 PHE B 48 0 SHEET 2 F 8 ILE B 378 VAL B 384 -1 O LYS B 383 N ILE B 46 SHEET 3 F 8 PHE B 369 VAL B 374 -1 N MET B 371 O GLY B 382 SHEET 4 F 8 THR B 245 PRO B 251 -1 N THR B 245 O VAL B 374 SHEET 5 F 8 CYS B 233 PRO B 239 -1 N VAL B 238 O ALA B 246 SHEET 6 F 8 VAL B 211 ASP B 228 -1 N ASP B 228 O CYS B 233 SHEET 7 F 8 LYS B 276 PRO B 285 -1 O LEU B 284 N MET B 217 SHEET 8 F 8 GLN B 361 VAL B 364 1 O GLN B 361 N GLU B 281 SHEET 1 G 5 ASP B 137 THR B 141 0 SHEET 2 G 5 PHE B 106 ASP B 117 1 N LEU B 114 O PHE B 139 SHEET 3 G 5 VAL B 178 ALA B 188 -1 O VAL B 181 N ALA B 113 SHEET 4 G 5 VAL B 325 VAL B 336 1 O SER B 326 N VAL B 178 SHEET 5 G 5 PHE B 287 GLN B 294 -1 N PHE B 287 O VAL B 336 SHEET 1 H 2 TRP B 190 THR B 192 0 SHEET 2 H 2 GLY B 340 ARG B 342 1 O THR B 341 N TRP B 190 SHEET 1 I 7 ILE C 46 PHE C 48 0 SHEET 2 I 7 ILE C 378 VAL C 384 -1 O LEU C 381 N PHE C 48 SHEET 3 I 7 PHE C 369 VAL C 374 -1 N PHE C 369 O VAL C 384 SHEET 4 I 7 THR C 245 PRO C 251 -1 N LEU C 247 O PHE C 372 SHEET 5 I 7 CYS C 233 PRO C 239 -1 N ARG C 234 O LEU C 250 SHEET 6 I 7 VAL C 211 ASP C 228 -1 N ASP C 228 O CYS C 233 SHEET 7 I 7 GLN C 200 TYR C 205 -1 N PHE C 204 O VAL C 212 SHEET 1 J 8 ILE C 46 PHE C 48 0 SHEET 2 J 8 ILE C 378 VAL C 384 -1 O LEU C 381 N PHE C 48 SHEET 3 J 8 PHE C 369 VAL C 374 -1 N PHE C 369 O VAL C 384 SHEET 4 J 8 THR C 245 PRO C 251 -1 N LEU C 247 O PHE C 372 SHEET 5 J 8 CYS C 233 PRO C 239 -1 N ARG C 234 O LEU C 250 SHEET 6 J 8 VAL C 211 ASP C 228 -1 N ASP C 228 O CYS C 233 SHEET 7 J 8 LYS C 276 PRO C 285 -1 O LEU C 284 N MET C 217 SHEET 8 J 8 GLN C 361 VAL C 364 1 O GLN C 361 N GLU C 281 SHEET 1 K 5 ASP C 137 THR C 141 0 SHEET 2 K 5 GLN C 107 ASP C 117 1 N THR C 116 O THR C 141 SHEET 3 K 5 VAL C 178 LYS C 187 -1 O PHE C 185 N SER C 109 SHEET 4 K 5 VAL C 325 VAL C 336 1 O GLU C 327 N MET C 180 SHEET 5 K 5 PHE C 287 GLN C 294 -1 N ILE C 289 O VAL C 334 SITE 1 AC1 7 TYR A 225 LEU A 227 ARG A 229 ARG A 234 SITE 2 AC1 7 ARG A 278 GLN A 361 HOH A1091 SITE 1 AC2 6 TYR B 225 LEU B 227 ARG B 229 ARG B 234 SITE 2 AC2 6 ARG B 278 GLN B 361 SITE 1 AC3 6 TYR C 225 LEU C 227 ARG C 229 ARG C 234 SITE 2 AC3 6 ARG C 278 GLN C 361 SITE 1 AC4 3 SER B 146 ASN B 171 LEU B 172 CRYST1 198.590 70.950 123.880 90.00 127.92 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005036 0.000000 0.003923 0.00000 SCALE2 0.000000 0.014094 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010233 0.00000